
Yu Jung Park
Articles
-
Aug 15, 2024 |
sciencedirect.com | Jonathan Chen |Dan Luo |Rui Li |Yu Jung Park
Hair loss is a global issue that affects people's overall health and cosmetic worry. Male and female pattern baldness affects 50 % of 50-year-old men and nearly 50 % of women.1 Alopecia Areata (AA), female pattern hair loss (FPHL), androgenetic alopecia (AGA), and telogen effluvium (TE) are the most common conditions among the patients. Currently, US Food and Drug Administration (FDA) has approved only four medicines for hair loss: Minoxidil, Finasteride, Baricitinib and Ritlecitinib.
-
Sep 29, 2023 |
mdpi.com | Jieun Lee |Hye Soo Park |Hee Jin Jung |Yu Jung Park
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →